Revolutionary Blood Test Aims to Transform Cancer Detection
Pearsanta, a subsidiary of Aditxt, develops a non-invasive blood test for early cancer detection, utilizing Mitomic® Technology. The test identifies mitochondrial DNA deletions as biomarkers for early disease detection from a blood sample. The Mitomic Prostate Test aims to reduce unnecessary biopsies,
